-
Hong Kong: Hong Kong has entered traditional peak season for seasonal influenza
(19 Mar 2010 00:19)
... traditional peak season for seasonal influenza. Influenza virus isolation in the CHPs Public Health Laboratory ... system also showed high seasonal activity of respiratory syncytial virus (RSV). The number of RSV detections ...
-
What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the
(19 Mar 2010 13:25)
... Fever * Diabetes * Ebola * Epstein-Barr Virus * Enterotoxigenic Escherichia coli * Helicobacter Pylori ... 3 * Parkinsons Disease * Plague * Respiratory Syncytial Virus * Ross River Virus * Shigellosis ...
-
Couple reluctantly seeks help after mold causes twins' potentially deadly illness
(16 Mar 2010 08:05)
... Onyx Neidigh are fighting a potentially deadly respiratory virus that doctors say was contracted through exposure ... their babies are being treated for respiratory syncytial virus at Mary Bridge Children's Hospital and ...
-
UTSA, UT Health Science Center win $1.5M from S.A. Life Sciences Institute
(16 Mar 2010 19:04)
... of National Mentoring Month activities Bio-pharmaceutical company ViroXis will be the first to move in ... and educational initiatives: Microencapsulated Delivery of Oncolytic Respiratory Syncytial Virus for Targeting Prostate Tumor In Vivo ...
-
Biopharmaceutical Stock Alert for GenVec Inc. Issued by StockPreacher
(15 Mar 2010 11:11)
... vaccine in animal health against foot-and-mouth disease and preventative vaccines for malaria, human immunodeficiency virus (HIV), respiratory syncytial virus and Herpes Simplex Virus Type 2 (HSV-2). "GNVC last week announced financial results ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
Alnylam and Collaborators Present New Pre-Clinical Research on RNAi Therapeutics Targeting PCSK9
(15 Mar 2010 11:21)
... most advanced program is in Phase II human clinical trials for the treatment of respiratory syncytial virus (RSV) infection. In addition, the company is developing RNAi therapeutics for the treatment of ...
-
GenVec Is Not Just a One Trick Pony
(15 Mar 2010 21:25)
... is developing vaccines (using the same adenovector technology) for influenza, HIV, malaria, foot-and-mouth disease, respiratory syncytial virus [RSV], and HSV-2. The attention that GNVC has received (in the form of financial ...
-
The pediatrician's role in raising awareness of respiratory syncytial virus
(11 Mar 2010 20:52)
...
-
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytom
(12 Mar 2010 17:16)
... Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced the initiation of a ... immunodeficiency virus (HIV), hepatitis C virus (HCV), respiratory syncytial virus (RSV) and influenza. The company's lead ...
-
Research and Markets: Antivirals: Novel Targets, Technologies, and Dealmaking
(11 Mar 2010 16:04)
... new report " The hottest field in antivirals is hepatitis C virus (HCV) drug development; ... treatment, novel drug targets, development compounds, companies. Respiratory syncytial virus (RSV): virus and disease, current treatment, ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results
(12 Mar 2010 13:40)
... our trivalent seasonal VLP influenza vaccine and identified a viable vaccine candidate to prevent respiratory syncytial virus (RSV). We have now conducted five human clinical studies for our pandemic and ...
-
Novavax Posts Wider-Than-Expected Loss; Investors Flee (NVAX)
(12 Mar 2010 14:23)
... our trivalent seasonal VLP influenza vaccine and identified a viable vaccine candidate to prevent respiratory syncytial virus (RSV). We have now conducted five human clinical studies for our pandemic and seasonal ...
-
GenVec Reports Fourth Quarter and 2009 Year-End Financial Results
(11 Mar 2010 21:31)
... of HIV vaccine candidates with GenVec's alternate adenovirus serotype technology. -- We received a Phase ... diseases including influenza, HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), and HSV-2. GenVec also discovers ...